SCHEMBL30176393

SCHEMBL30176393

Cc1cc(-n2c(C3CC3)c(C(Cc3ccccc3)C(=O)O)c3cc(O)ccc32)ccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.40
S1PR3 Q99500 3/20 0.40
GAA P10253 2/20 0.39
GFER P55789 1/20 0.39
HPGD P15428 2/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
PTGES O14684 1/20 0.35
MAPT P10636 2/20 0.35
PKM P14618 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23887040 1.00 PLA2G2A (0.40) PLA2G2AS1PR3GAAGFERHPGD
SCHEMBL30176391 1.00 PLA2G2A (0.40) PLA2G2AS1PR3GAAGFERHPGD
SCHEMBL30176346 0.89 HTR3A (0.42) PLA2G2ASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL23886835 0.89 HTR3A (0.42) PLA2G2ASMN1; SMN2MEN1KMT2AMAPT
SCHEMBL23898352 0.87 GAA (0.45) PLA2G2AS1PR3GAAGFERHPGD
SCHEMBL23886750 0.83 HTR3A (0.42) PLA2G2AMEN1KMT2AMAPT
SCHEMBL30176263 0.83 HTR3A (0.42) PLA2G2AMEN1KMT2AMAPT
SCHEMBL30337916 0.83 HTR3A (0.42) PLA2G2AMEN1KMT2AMAPT
SCHEMBL23898350 0.78 PLA2G2A (0.45) PLA2G2AS1PR3GAAGFERHPGD
SCHEMBL23898349 0.76 KMT2A (0.43) GAAGFERHPGDLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126817-A1 SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed